Asawari has a broad academic background in life sciences, biochemistry and food science. She works in the Life Sciences team where she supports clients in a range of technology areas including precision medicine, gene therapy, bioinformatics, medical devices and diagnostics.
Prior to joining Keltie in 2022, Asawari worked in the patent litigation team of a leading City law firm for over six years where she worked on contentious matters within the pharmaceutical and biotech space. She also has experience working in a technology transfer office for three years where she enjoyed interacting with academic inventors and understanding the role of IP in the commercialisation of research.
Before moving to the UK, Asawari worked in a DNA sequencing laboratory in Seattle for around three years.
16.01.2023Gene Editing : CRISPR breakthroughs highlight IP questions
There have been some exciting announcements about the application of CRISPR-Cas9 type gene-editing technology to treat serious illnesses in the past few weeks. But this complex and rapidly evolving area of medicine raises some challenging IP issues.